First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.
UCSF Interventional Cardiology Experts Perform Novel Tricuspid and Mitral Valve Procedures
UC San Francisco interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.
Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers Find
Patients with a detectable prostate-specific antigen (PSA) after radical prostatectomy (RP) may have excellent long-term outcomes, according to two retrospective studies conducted by UCSF researchers.
Susceptibility to Pathogenic T Cells in Chronic Lung Disease May have a Genetic Basis
Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue, and leading to one of the most common ...
Chances of Receiving Percutaneous Coronary Intervention in a Low-Volume Facility are Increasing, Despite Worse Outcomes
There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes.
UCSF Surgical Oncologists Present Clinical Findings at International Conference
The latest advances in surgical cancer care and research were showcased at the Society of Surgical Oncology’s (SSO) Annual Meeting, the International Conference on Surgical Cancer Care. The meeting was held in Boston, from March 22 – 25, 2023.
Some Patients with Lung Disease Fare Worse Than Others. Could Sleep Explain It?
Flare-Ups in COPD Linked to Sleeplessness, UCSF-Led Study Shows
How the Cardiogenic Shock Team Improves Patient Outcomes at UCSF
A 69-year-old woman with heart failure with reduced ejection fraction caused by left ventricular noncompaction (LVNC) came to the UCSF emergency department with tachycardia, dizziness, shortness of breath and swelling, despite taking all ...
UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UC San Francisco’s Heart and Vascular Center has been recognized by The American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry.
UCSF Neurologist Recognized for Innovative Epilepsy Research
UCSF Neurologist Recognized for Innovative Epilepsy Research American Academy of Neurology to Honor Jon Kleen, MD, PhD with 2023 Dreifuss-Penry Epilepsy Award
Electroconvulsive Therapy for Status Epilepticus and a Genetic Diagnosis for Epilepsy and Renal Failure: UCSF Neurohospitalist Cases
One of the first of its kind, the UCSF Neurohospitalist Program specializes in caring for hospitalized patients with complex neurologic disorders.
In Utero Enzyme Replacement Therapy
Pregnant patients with a diagnosed fetal lysosomal storage disease may have the opportunity to receive a promising treatment that could improve their babies’ health after birth.
Minimally Invasive LITT Effective for Recurrent Glioblastoma: A UCSF Case Study
A 65-year-old woman with a small focal recurrence of glioblastoma was treated with laser interstitial thermal therapy (LITT) at UCSF nearly five years after her first tumor resection surgery.
Ross Procedure the Right Choice for Active Patient With Aortic Stenosis
A 52-year-old man with severe aortic stenosis chose to undergo a Ross procedure at UCSF during which surgeons replaced his diseased aortic valve with his own pulmonary valve. He was discharged within a week and is recovering well.
Structural Heart Disease Expert Leads UCSF Interventional Cardiology Program
Sammy Elmariah, MD, MPH, has joined UCSF as chief of the Interventional Cardiology Program and medical director of the cardiac catheterization lab.